Truepill is a Healthtech company based in San Francisco, CA. It has raised $256M in total funding. Latest round: Series D.
Truepill funding overview
Truepill is a Healthtech company based in San Francisco, CA. Truepill has raised $256M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in October 2021. The round record for Truepill runs through 2021; nothing later has been disclosed. Investors on record include Y Combinator, Oak HC/FT, Optum Ventures, Index Ventures, Foundation Capital, Social Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Truepill at a glance
Total raised
$256M
Latest round
Series D
Latest round date
October 2021
Industry
Healthtech
Headquarters
San Francisco, CA
Notable investors
Y Combinator, Oak HC/FT, Optum Ventures, Index Ventures, Foundation Capital, Social Capital, Sound Ventures, Initialized Capital
Frequently asked about Truepill funding
How much has Truepill raised?
Truepill has raised $256M in total disclosed funding across the rounds on record.
Who has invested in Truepill?
Y Combinator, Oak HC/FT, Optum Ventures, Index Ventures, Foundation Capital, Social Capital are named among the investors backing Truepill.
What was the latest Truepill funding round?
The most recent disclosed round is a Series D, announced in October 2021.
Where is Truepill based?
Truepill is based in San Francisco, CA.
What sector does Truepill operate in?
Truepill is tracked under Healthtech from San Francisco, CA, with $256M in disclosed funding.
When did Truepill last raise?
The last disclosed Truepill round closed in October 2021 at Series D.
Every Truepill figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in San Francisco at a similar stage.
